Introduction: Metabolic acidosis (MA) is a frequent alteration in chronic kidney disease (CKD) that is associated with numerous complications, which is why its correction is recommended. Oral sodium bicarbonate is currently the treatment of choice. Objective: The objective is to determine if venous bicarbonate is equal to arterial bicarbonate in the follow-up of a patient with chronic kidney disease. Materials Methods: Single-center Cross-sectional studies in a cohort of adult patients with stage 4 - 5 CKD. Samples were taken between January 2022 and January 2023, in a Clinic in the city of Ibague/ Colombia obtained from the radial artery. The inclusion criteria were: not being treated with alkaline at the time of inclusion. Results: A total of 71 patients were included, 73.2% male (52) and 26.8% female (19), with different stages: stage 3 with 5.6% (4), stage 4 with 60.6% (43), stage 5 with 33.8% (23). 66.2% were diabetic, 88.7% had arterial hypertension, and 15.5% of the patients presented hematoma as a complication and pain associated with arterial puncture. The result of mean venous bicarbonate was 18.8 with a standard deviation of 2.3, arterial bicarbonate a mean of 19.4 with a standard deviation of 2.1 with a value of P 0.46, venous pH with a mean of 7.37 with a standard deviation of 0.48 and a mean arterial pH of 7.38 with a standard deviation of 0.48 with a P value of 0.01. Values of venous bicarbonate compared to arterial bicarbonate showed no statistically significant difference in patients with chronic kidney disease, but there were more complications such as hematoma and pain in patients in the arterial puncture cohort, because of this result venous bicarbonate corresponds to arterial bicarbonate, but has less risk of complications associated with the procedure. Conclusion: Metabolic acidosis is a frequent alteration in advanced chronic kidney disease, these results showed that the values of arterial and venous bicarbonate have no statistically significant differences, but there is a greater risk of complications with arterial blood gases, due to this, venous bicarbonate could be a useful tool for patients with chronic kidney disease.
Goraya, N., Simoni, J., Sager, L.N., Pruszynski, J. and Wesson, D.E. (2018) Acid Retention in Chronic Kidney Disease Is Inversely Related to GFR. American Journal of Physiology-Renal Physiology, 314, F985-F991. https://doi.org/10.1152/ajprenal.00463.2017
Kraut, J.A. and Madias, N.E. (2016) Metabolic Acidosis of CKD: An Update. American Journal of Kidney Diseases, 67, 307-317. https://doi.org/10.1053/j.ajkd.2015.08.028
Moranne, O., Froissart, M., Rossert, J., Gauci, C., Boffa, J.J., Haymann, J.P., et al. (2009) NephroTest Study Group Timing of Onset of CKD-Related Metabolic Complications. Journal of the American Society of Nephrology, 20, 164-171. https://doi.org/10.1681/ASN.2008020159
Raphael, K.L. (2018) Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD. Journal of the American Society of Nephrology, 29, 376-382. https://doi.org/10.1681/ASN.2017040422
Goraya, N., Simoni, J., Sager, L.N., Madias, N.E. and Wesson, D.E. (2019) Urine Citrate Excretion as a Marker of Acid Retention in Patients with Chronic Kidney Disease without Overt Metabolic Acidosis. Kidney International, 95, 1190-1196. https://doi.org/10.1016/j.kint.2018.11.033
Kalantar-Zadeh, K., Mehrotra, R., Fouque, D. and Kopple, J.D. (2004) Metabolic Acidosis and Malnutrition-Inflammation Complex Syndrome in Chronic Renal Failure. Seminars in Dialysis, 17, 455-465. https://doi.org/10.1111/j.0894-0959.2004.17606.x
Eustace, J.A., Astor, B., Muntner, P.M., Ikizler, T.A. and Coresh, J. (2004) Prevalence of Acidosis and Inflammation and Their Association with Low Serum Albumin in Chronic Kidney Disease. Kidney International, 65, 1031-1040. https://doi.org/10.1111/j.1523-1755.2004.00481.x
Mak, R.H.K. (1998) Effect of Metabolic Acidosis on Insulin Action and Secretion in Uremia. Kidney International, 54, 603-607. https://doi.org/10.1046/j.1523-1755.1998.00023.x
Esche, J., Shi, L., Sánchez-Guijo, A., Hartmann, M.F., Wudy, S.A. and Remer, T. (2016) Higher Diet-Dependent Renal Acid Load Associates with Higher Glucocorticoid Secretion and Potentially Bioactive Free Glucocorticoids in Healthy Children. Kidney International, 90, 325-333. https://doi.org/10.1016/j.kint.2016.02.033
Dobre, M., Yang, W., Chen, J., Drawz, P., Hamm, L.L., Horwitz, E., et al. (2013) Association of Serum Bicarbonate with Risk of Renal and Cardiovascular Outcomes in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases, 62, 670-678. https://doi.org/10.1053/j.ajkd.2013.01.017
Shah, S.N., Abramowitz, M., Hostetter, T.H. and Melamed, M.L. (2009) Serum Bicarbonate Levels and the Progression of kidney Disease: A Cohort Study. American Journal of Kidney Diseases, 54, 270-277. https://doi.org/10.1053/j.ajkd.2009.02.014
Raphael, K.L., Zhang, Y., Wei, G., Greene, T., Cheung, A.K. and Beddhu, S. (2013) Serum Bicarbonate and Mortality in Adults in NHANES III. Nephrology Dialysis Transplantation, 28, 1207-1213. https://doi.org/10.1093/ndt/gfs609
Navaneethan, S.D., Schold, J.D., Arrigain, S., Jolly, S.E., Wehbe, E., Raina, R., et al. (2011) Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology, 6, 2395-2402. https://doi.org/10.2215/CJN.03730411
Kraut, J.A. and Madias, N.E. (2017) Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease. Advances in Chronic Kidney Disease, 24, 289-297. https://doi.org/10.1053/j.ackd.2017.06.005
Dubey, A.K., Sahoo, J., Vairappan, B., Haridasan, S., Parameswaran, S. and Priyamvada, P.S. (2018) Correction of Metabolic Acidosis Improves Muscle Mass and Renal Function in Chronic Kidney Disease Stages 3 and 4: A Randomized Controlled Trial. Nephrology Dialysis Transplantation, 35, 121-129. https://doi.org/10.1093/ndt/gfy214
Giner, J., Casan, P., Belda, J., Gonzalez, M., Miralda, R.M. and Sanchis, J. (1996) Pain during Arterial Puncture. Chest, 110, 1443-1445. https://doi.org/10.1378/chest.110.6.1443
Malatesha, G., Singh, N., Bharija, A., Rehani, B. and Goel, A. (2007) Comparison of Arterial and Venous pH, Bicarbonate, pCO2 and pO2 in Initial Emergency Department Assessment. Emergency Medicine Journal, 24, 569-571. https://doi.org/10.1136/emj.2007.046979
Criscuolo, C., Nepper, G. and Buchalter, S. (1995) Reflex Sympathetic Dystrophy Following Arterial Blood Gas Sampling in the Intensive Care Setting. Chest, 108, 578-580. https://doi.org/10.1378/chest.108.2.578
Brandenburg, M.A. and Dire, D.J. (1998) Comparison of Arterial and Venous Blood Gas Values in the Initial Emergency Department Evaluation of Patients with Diabetic Ketoacidosis. Annals of Emergency Medicine, 31, 459-465. https://doi.org/10.1016/S0196-0644(98)70254-9
Raphael, K.L., Carroll, D.J., Murray, J., Greene, T. and Beddhu, S. (2017) Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease. Journal of the American Society of Nephrology, 28, 2483-2490. https://doi.org/10.1681/ASN.2016101151
Raphael, K.L., Zhang, Y., Ying, J. and Greene, T. (2014) Prevalence of and Risk Factors for Reduced Serum Bicarbonate in Chronic Kidney Disease. Nephrology (Carlton), 19, 648-654. https://doi.org/10.1111/nep.12315
Meza García, M. (2011) Acid-Base Disturbances in Critically Ill Patients. Acta Medica Peruana, 28, 46-55.
Krieger, N.S., Frick, K.K. and Bushinsky, D.A. (2004) Mechanism of Acid-Induced Bone Resorption. Current Opinion in Nephrology and Hypertension, 13, 423-436. https://doi.org/10.1097/01.mnh.0000133975.32559.6b
Reaich, D., Price, S.R., England, B.K. and Mitch, W.E. (1995) Mechanisms Causing Muscle Loss in Chronic Renal Failure. American Journal of Kidney Diseases, 26, 242-247. https://doi.org/10.1016/0272-6386(95)90179-5
Dobre, M., Yang, W., Pan, Q., et al. (2015) Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients with Chronic Kidney Disease (CKD): A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Heart Association, 4, e001599. https://doi.org/10.1161/JAHA.114.001599
Kovesdy, C.P. anderson, J.E. and Kalantar-Zadeh, K. (2009) Association of Serum Bicarbonate Levels with Mortality in Patients with Non-Dialysis-Dependent CKD. Nephrology Dialysis Transplantation, 24, 1232-1237. https://doi.org/10.1093/ndt/gfn633
Goraya, N., Simoni, J., Jo, C.H. and Wesson, D.E. (2013) A Comparison of Treating Metabolic Acidosis in CKD Stage 4 Hypertensive Kidney Disease with Fruits and Vegetables or Sodium Bicarbonate. Clinical Journal of the American Society of Nephrology, 8, 371-381. https://doi.org/10.2215/CJN.02430312
Goraya, N. and Wesson, D.E. (2017) Management of the Metabolic Acidosis of Chronic Kidney Disease. Advances in Chronic Kidney Disease, 24, 298-304. https://doi.org/10.1053/j.ackd.2017.06.006
Remer, T. and Manz, F. (1995) Potential Renal Acid Load of Foods and Its Influence on Urine pH. Journal of the American Dietetic Association, 95, 791-797. https://doi.org/10.1016/S0002-8223(95)00219-7
Raphael, K., Wei, G., Baird, B., Greene, T. and Beddhu, S. (2011) Higher Serum Bicarbonate Levels within the Normal Range Are Associated with Better Survival and Renal Outcomes in African Americans. Kidney International, 79, 356-362. https://doi.org/10.1038/ki.2010.388